PatientsLikeMe ™

MS
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: HCTZ, Hydrochlorot, Microzide
See also: Diovan HCT®, Micardis HCT, Prinzide

What is Hydrochlorothiazide? Hydrochlorothiazide is an antihypertensive diuretic drug used in the treatment of high blood pressure and/or swelling. Hydrochlorothiazide is also known as HCT, HCTZ, or HZT. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

69 patients in the community are taking or have taken Hydrochlorothiazide.

Reason # Patients Percentage of patients
Other 51 79%
General health 7 10%
High blood pressure 2 3%
Mood swings 1 1%
Bladder problems 1 1%
Cramps, calf muscles 1 1%
Don't know 1 1%

Dosages

Based on the patients currently taking Hydrochlorothiazide.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 day 0.25 mg day 6.25 mg day 10 mg day 12.5 mg day 25 mg day 40 mg day 50 mg day 160 mg day 200 mg day
  3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 4 Number of Patients: 4 9 Number of Patients: 9 33 Number of Patients: 33 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Hydrochlorothiazide or how long patients were taking Hydrochlorothiazide before stopping.

Currently taking Hydrochlorothiazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
8
5
8
10
21

Stopped taking Hydrochlorothiazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
3
0
2
0
1
Why Patients Stopped Taking Hydrochlorothiazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 3 50% Doctor's advice: 50%
Personal research 2 33% Personal research: 33%
Other 1 17% Other: 17%
Course of treatment ended 1 17% Course of treatment ended: 17%


Back to top